Supernus, United Therapeutics sales and marketing update

United Therapeutics launched Orenitram treprostinil ER in the U.S. to treat pulmonary arterial hypertension (PAH). A wholesale acquisition cost for 100 tablets is $487.50 for the 0.125 mg strength, $...